SUBMISSIONS

Accepted, conditional and declined samples

Which materials fit Axiom's current methods, which require preflight review, and which are outside present testing scope.

SOURCES LAST REVIEWED 2026-08-27

A catalog listing or familiar product name does not by itself guarantee acceptance or release. Axiom confirms the exact analyte, physical presentation, reference material, method fit, criteria, lawful authority, and available material. Conditional requests may be drafted, but staff must clear their stated hold before the affected step proceeds.

Does Axiom accept Peptides?

Examples in the current method scope include BPC-157, semaglutide, tirzepatide, CJC-1295, ipamorelin, TB-500, KPV, and blends of them. Supported presentations: Lyophilized powder, aqueous solution, cartridge. Final acceptance still depends on the exact declared product and material review.

Does Axiom accept Peptide blends?

Examples in the current method scope include Any combination of the peptides above. Supported presentations: Lyophilized powder, aqueous solution. Important limitation: A blend is certified per component. An area percent across a blend is not a purity figure for any one of them.

Does Axiom accept Peptide hydrolysates?

Examples in the current method scope include Cerebrolysin, cerebroprotein hydrolysate. Supported presentations: Lyophilized powder, aqueous solution. Important limitation: These are defined mixtures, not single molecules, so the certificate carries a molecular-weight distribution and a composition profile instead of an accurate mass and a purity percent. Tell us which preparation you sent: Cerebrolysin and the generic cerebroprotein hydrolysates have different peptide profiles, and a result from one says nothing about the other.

Does Axiom accept Amino acids?

Examples in the current method scope include L-arginine, L-citrulline, L-methionine, L-ornithine. Supported presentations: Lyophilized powder, aqueous solution. Important limitation: These respond weakly at our purity wavelength, so quantitation is by mass rather than by area percent.

Does Axiom accept Small molecules with a real chromophore?

Examples in the current method scope include 5-Amino-1MQ, AICAR, SLU-PP-332, thiamine, pyridoxine, methylene blue. Supported presentations: Lyophilized powder, aqueous or oil solution, capsule, tablet. Final acceptance still depends on the exact declared product and material review.

Does Axiom accept Catalog oral products?

Examples in the current method scope include Exact supplier-listed tablets and capsules, including catalog SARMs and ancillary small molecules. Supported presentations: Tablet, capsule. Important limitation: Intake is conditional on the exact SKU. Product-specific reference material, method fit, source-backed criteria, and the submitted strength remain face-up release gates; a peptide panel is never substituted for an oral small-molecule method.

Does Axiom accept Oil and other non-aqueous preparations?

Examples in the current method scope include Exact catalog injection presentations whose vehicle is declared as oil or another non-aqueous carrier. Supported presentations: Solution or suspension; vehicle recorded separately as oil, aqueous, mixed, or unknown. Important limitation: Vehicle identity is not inferred from a supplier section heading. Unknown carrier composition remains a release hold, and Schedule III articles also require verified customer authorization before shipping or custody.

Does Axiom accept Vitamins and cofactors?

Examples in the current method scope include Methylcobalamin and cyanocobalamin (B12), NAD+. Supported presentations: Lyophilized powder, aqueous solution. Important limitation: B12 is photolabile, and the cyano and methyl forms are distinct molecules. Tell us which one you sent.

Does Axiom accept Polar small molecules?

Examples in the current method scope include L-carnitine, choline chloride, myo-inositol. Supported presentations: Lyophilized powder, aqueous solution. Important limitation: These are invisible to a reverse-phase purity method and are quantified on a separate lane.

Does Axiom accept Copper peptide complexes?

Examples in the current method scope include GHK-Cu, AHK-Cu. Supported presentations: Lyophilized powder, aqueous solution. Important limitation: The copper is not held by a covalent bond and our standard purity lane strips it. These are quantified on a method that leaves the complex intact, and the copper content is reported separately.

Does Axiom need to review Schedule III anabolic steroids and testosterone esters?

This category requires conditional preflight review. Schedule III testing is conditionally available. You may select and save the exact product now, but Axiom will not release a shipping address, accept custody, or begin work until the submitting company or account has a current verified authorization for the registered location and schedule.

Does Axiom need to review Catalog oral small molecules and SARMs?

This category requires conditional preflight review. Catalog tablets, capsules, and related small molecules may enter conditional testing. The exact analyte, presentation, matched reference standard, method, and face-up acceptance criteria must be bound before conformance or COA release; a peptide method is never substituted just because it is on the bench.

Does Axiom need to review Oil and other non-aqueous vehicles?

This category requires conditional preflight review. Oil vehicles are supported as a separate controlled presentation. Declare the vehicle exactly; oil-specific preparation, method suitability, reference material, and acceptance criteria remain visible release holds until they are qualified for that product.

Does Axiom accept Cannabinoids and hemp extracts?

No, this category is outside Axiom's current testing scope. Cannabinoid potency is a different method on a different matrix, and it is separately regulated at state level. We do not offer it.

Does Axiom need to review Other prescription drugs and hormone therapies?

This category requires conditional preflight review. Exact products already present in the controlled catalog may enter conditional testing. Unlisted finished drug products require a method-and-authority preflight; no peptide panel, generic product family, or customer label substitutes for product-specific criteria.

Does Axiom accept Botanical tinctures and undefined extracts?

No, this category is outside Axiom's current testing scope. An extract has no single molecular identity, so there is no accurate mass to confirm and an area percent would not mean what it appears to mean.

What are common situations where Axiom is not the right lab?

Axiom currently declines cannabinoid or hemp potency work and botanical tinctures or undefined extracts. A request is also not a fit when it requires a method Axiom does not offer, asks for clinical diagnosis or safety/efficacy conclusions, depends on an unidentified molecule or unsupported matrix, lacks lawful possession or shipping authority, or requires accreditation Axiom does not hold. Staff may recommend an appropriately scoped or accredited laboratory without endorsing a specific result.

Can Sona promise that an unusual sample will be accepted?

No. Sona may explain published scope and collect the exact product name, physical form, carrier or matrix, label claim, lot, available amount, requested question, and intended service. Conditional or unclear requests must become a technical preflight ticket; Sona must not promise custody, method suitability, conformance, or release.

Need a person?
Call or text (279) 236-4800, start a site chat, or open a tracked ticket.
← ALL HELP ARTICLES